eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Allergan Ltd

Marlow International, The Parkway, Marlow, Bucks, SL7 1YL, UK
Telephone: +44 (0)1628 494444
Fax: +44 (0)1628 494449
WWW: http://www.allergan.co.uk
Medical Information Direct Line: +44 (0)1628 494026
Medical Information e-mail: UK_MedInfo@Allergan.com
Out of Hours contact: +44 (0)1628 494026

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 28/10/2011
PIL Relestat 0.5 mg/ml, eye drops, solution

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 28/10/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to, or new, use for medicine
  • Change to side-effects
Updated on 26/07/2010 and displayed until 28/10/2011
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
  • Change to date of revision
Updated on 15/04/2009 and displayed until 26/07/2010
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
  • Change to date of revision
  • Change due to user-testing of patient information
Updated on 31/08/2007 and displayed until 15/04/2009
Reasons for adding or updating:
  • Change to Further Information section
  • Change to MA holder contact details
Updated on 08/07/2004 and displayed until 31/08/2007
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
   epinastine hydrochloride